Sekerdag, E. Et Al. 2017. Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma. 23rd World Congress of Neurology (WCN) , (Kyoto, Japan), 171-172.

Sekerdag, E., LULE, S., PEHLİVAN, S., KARA, A., OZTURK, N., KAFFASHI, A., ... VURAL, İ.(2017). Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma . 23rd World Congress of Neurology (WCN) (pp.171-172). Kyoto, Japan

Sekerdag, MELİKE Et Al. "Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma," 23rd World Congress of Neurology (WCN), Kyoto, Japan, 2017

Sekerdag, MELİKE M. Et Al. "Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma." 23rd World Congress of Neurology (WCN) , Kyoto, Japan, pp.171-172, 2017

Sekerdag, E. Et Al. (2017) . "Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma." 23rd World Congress of Neurology (WCN) , Kyoto, Japan, pp.171-172.

@conferencepaper{conferencepaper, author={MELİKE MUT AŞKUN Et Al. }, title={Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma}, congress name={23rd World Congress of Neurology (WCN)}, city={Kyoto}, country={Japan}, year={2017}, pages={171-172} }